Works matching IS 14611457 AND DT 2004 AND VI 7 AND IP 2

Results: 16

A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 125, doi. 10.1017/s1461145704004262

By:

Piet Oosthuizen;
Robin Emsley;
H. Jadri Turner;
Natasha Keyter

Publication type:

Article

Focus on Polypharmacy in schizophrenia: does anyone truly benefit? See Suzuki et al. p. 133142. Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia..

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 109, doi. 10.1017/s1461145704004183

By:

Donald C. Goff;
Oliver Freudenreich

Publication type:

Article

Evidence-based pharmacotherapy of schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 219, doi. 10.1017/s1461145704004171

By:

Robin Emsley;
Piet Oosthuizen

Publication type:

Article

Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 183, doi. 10.1017/s146114570400416x

By:

Katharina Domschke;
Christine M. Freitag;
Gregor Kuhlenbäumer;
Anja Schirmacher;
Philipp Sand;
Peter Nyhuis;
Christian Jacob;
Jürgen Fritze;
Petra Franke;
Marcella Rietschel;
Henk S. Garritsen;
Rolf Fimmers;
Markus M. Nöthen;
Klaus-Peter Lesch;
Florian Stögbauer

Publication type:

Article

Reviewers for 2003.

Published in:: International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 241, doi. 10.1017/s1461145704004158
Publication type:: Article

Focus on Antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence?

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 113, doi. 10.1017/s1461145704004146

By:

Stephen M. Stahl

Publication type:

Article

Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 193, doi. 10.1017/s1461145704004080

By:

David A. Morilak;
Alan Frazer

Publication type:

Article

Simultaneous depletion of tryptophan, tyrosine and phenylalanine as an experimental method to probe brain monoamine function in humans.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 171, doi. 10.1017/s1461145703004073

By:

Pradeep J. Nathan;
Jay-Maree Hughes;
Bernie McInerney;
Ben J. Harrison

Publication type:

Article

Association of a functional −1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 189, doi. 10.1017/s1461145703004061

By:

Claudia Rothe;
Lise Gutknecht;
Christine Freitag;
Ralf Tauber;
Rainald Mössner;
Petra Franke;
Jürgen Fritze;
Gerd Wagner;
Gregor Peikert;
Berit Wenda;
Philipp Sand;
Christian Jacob;
Marcella Rietschel;
Markus M. Nöthen;
Henk Garritsen;
Rolf Fimmers;
Jürgen Deckert

Publication type:

Article

Citalopram challenge in social anxiety disorder.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 177, doi. 10.1017/s146114570300405x

By:

Jakov Shlik;
Eduard Maron;
Innar Tõru;
Anu Aluoja;
Veiko Vasar

Publication type:

Article

Switching elderly chronic psychotic patients to olanzapine.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 165, doi. 10.1017/s1461145703004048

By:

Yoram Barak;
Eyal Shamir;
Ilona Mirecki;
Ronit Weizman;
Dov Aizenberg

Publication type:

Article

Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 155, doi. 10.1017/s1461145703004036

By:

Lucyna Antkiewicz-Michaluk;
Jadwiga Wardas;
Jerzy Michaluk;
Irena Romańska;
Andrzej Bojarski;
Jerzy Vetulani

Publication type:

Article

A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 117, doi. 10.1017/s1461145703004024

By:

Önder Tuǧal;
Kâzım M. Yazıcı;
A. Elif Anıl Yaǧcıoǧlu;
Ahmet Göǧüş

Publication type:

Article

Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 133, doi. 10.1017/s1461145703004012

By:

Takefumi Suzuki;
Hiroyuki Uchida;
Kenji F. Tanaka;
Kensuke Nomura;
Harumasa Takano;
Akira Tanabe;
Koichiro Watanabe;
Gohei Yagi;
Haruo Kashima

Publication type:

Article

Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 143, doi. 10.1017/s1461145703004000

By:

Guo-Qiang Xing;
Shani Russell;
Maree J. Webster;
Robert M. Post

Publication type:

Article

Menstrual disturbances a rare side-effect of bright-light therapy.

Published in:

International Journal of Neuropsychopharmacology, 2004, v. 7, n. 2, p. 239, doi. 10.1017/s1461145703003997

By:

Edda Pjrek;
Dietmar Winkler;
Matthäus Willeit;
Anastasios Konstantinidis;
Nikolaus Thierry;
Siegfried Kasper

Publication type:

Article